| 93.RD |
National Institute of Health
|
$59.46M |
-
|
0 |
| 93.498 |
Stimulus Act: Provider Relief Fund
|
$59.34M |
Yes
|
0 |
| 84.268 |
U.s. Department of Education: Stafford Loan
|
$43.31M |
-
|
0 |
| 84.268 |
U.s. Department of Education: Grad Plus
|
$24.04M |
-
|
0 |
| 93.323 |
Passed Through City of Chicago-Chicago Department of Public Health: Connect Chicago Covid 19
|
$3.07M |
Yes
|
0 |
| 93.323 |
Passed Through City of Chicago-Chicago Department of Public Health: Regional Innovative Public Health Laboratory (riphl)
|
$2.32M |
Yes
|
0 |
| 93.323 |
Passed Through City of Chicago-Chicago Department of Public Health: Cdph-Datahub
|
$2.08M |
Yes
|
0 |
| 93.461 |
Stimulus Act: Uninsured Covid Testing and Treatment
|
$1.98M |
Yes
|
0 |
| 93.788 |
Passed Through State of Illinois Department of Human Services: Opioid Sor 2 Program
|
$1.53M |
-
|
0 |
| 93.855 |
Passed Through Brigham and Women's Hospital: Aids Clincial Trial Group Network
|
$1.39M |
-
|
0 |
| 84.425F |
Stimulus Act: Higher Education Emergency Relief Fund: Institutional Portion
|
$1.29M |
Yes
|
0 |
| 84.038 |
U.s. Department of Education: Perkins Loan-Outstanding Loan Bal. at Measurement Date
|
$1.25M |
-
|
0 |
| 93.788 |
Passed Through State of Illinois Department of Human Services: Opioid Sor Program
|
$1.11M |
-
|
0 |
| 93.310 |
National Institute of Health:covid Alive Church Network: Increasing Covid-19 Testing in Chicago African American Testing Deserts
|
$850,381 |
-
|
0 |
| 84.425E |
Stimulus Act: Higher Education Emergency Relief Fund: Student Portion
|
$786,652 |
Yes
|
0 |
| 93.866 |
Passed Through University of Pittsburgh: the Study of Women's Health Across the Nation (swan):the Impact of Midlife and the Menopause Transition on Healthand Functioning in Early Old Agepreaward Approved 7/2/20
|
$768,226 |
-
|
0 |
| 93.368 |
Passed Through University of Chicago: Illinois Precision Medicine Consortium
|
$714,790 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Multi-Omic Network Directed Proteoform Discovery, Dissectionand Functional Validation to Prioritize Novel Ad Therapeutictargets
|
$694,875 |
-
|
0 |
| 93.350 |
Passed Through University of Chicago: Itm 2.0: Advancing Translational Science in Metropolitan Chicago
|
$683,854 |
-
|
0 |
| 93.264 |
U.s. Department of Health and Human Services: Nurse Faculty Loan Program-Outstanding Loan Bal. at Measurement Date
|
$628,638 |
-
|
0 |
| 93.268 |
Passed Through City of Chicago-Chicago Department of Public Health: Healthy Chicago Equity Zone
|
$551,977 |
-
|
0 |
| 93.994 |
Passed Through State of Illinois Department of Public Health: School Based Health Center
|
$528,456 |
-
|
0 |
| 93.847 |
National Institute of Health:covid Covid 19 Cytokine Storm
|
$513,740 |
-
|
0 |
| 93.866 |
Passed Through Vanderbilt University: A Randomized, Double-Blind, Placebo-Controlled Trial of Urate-Elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson Disease.
|
$476,249 |
-
|
0 |
| 93.342 |
U.s. Department of Health and Human Services: Loans for Disadvantaged Students-Outstanding Loan Bal. at Measurement Date
|
$416,493 |
-
|
0 |
| 93.RD |
Passed Through Cdc: Innovative Support for Patients with Sar Sarscov2 Infections(inspire) Registry
|
$402,490 |
-
|
0 |
| 93.866 |
National Institute of Health:covid Impact of Covid-19 on Ad Occurrence: A Biracial Intergenerational Population Study
|
$400,505 |
-
|
0 |
| 93.364 |
U.s. Department of Health and Human Services: Nursing Student Loan-Graduate-Outstanding Loan Bal. at Measurement Date
|
$382,658 |
-
|
0 |
| 84.305 |
Department of Education: Web-Based Assessment of Social-Emotional Skills in Middle School
|
$368,236 |
-
|
0 |
| 93.994 |
Passed Through State of Illinois Department of Public Health: Regional Perinatal Network
|
$359,105 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Racial Differences in Decision Making Among Olderadults
|
$344,894 |
-
|
0 |
| 93.866 |
Passed Through Mt. Sinai: Peripheral and Brain Levels of Advanced Glycation End Products Ages and Incident Alzheimers Disease and Neuropathy
|
$322,496 |
-
|
0 |
| 84.033 |
U.s. Department of Education: Federal Work Study
|
$317,607 |
-
|
0 |
| 93.273 |
National Institute of Health:covid Alcohol Misuse: An Independent Risk Factor That Increases the Incidence and Severity of Covid-19
|
$303,303 |
-
|
0 |
| 93.866 |
Passed Through Sunnybrook Research Institute: Sleep, Cicadian Rhythms, and Mechanisms of Cognitive Declinein the Human Brain
|
$289,642 |
-
|
0 |
| 93.866 |
Passed Through Iit: In-Vivo Mri-Based Prediction of Tdp43 Pathologyin Aging
|
$274,884 |
-
|
0 |
| 93.866 |
Passed Through Vanderbilt University: Brain-Icu 2 Study: Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction (dementia) in Icu Survivors, 2nd Study
|
$269,877 |
-
|
0 |
| 93.853 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla the Clinical Significance of Incidental White Matter Lesions on Mri Amongst A Diverse Population with Cognitive Complaint
|
$258,583 |
-
|
0 |
| 93.847 |
Passed Through Wistar Institute: Glycomic Modulation of Gut Microbiomeduring Hiv Infection
|
$252,532 |
-
|
0 |
| 93.866 |
Passed Through Mt. Sinai: Leveraging Existing Aging Research Networks to Investigate Tbi and Ad/adrd Risk (learn Tbi & Ad)
|
$243,632 |
-
|
0 |
| 93.823 |
Passed Thru Harvard School of Public Health: Safety and Healthcare Epidemiology Prevention Research Development (shepherd) Program
|
$241,298 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Multi-Omic Network Directed Proteoform Discovery, Dissection and Functional Validation to Prioritize Novel Ad Therapeutic Targets
|
$241,000 |
-
|
0 |
| 93.855 |
Passed Through University of Wisconsin: Harnessing Adaptive Nk Cell Transfer to Deplete Viral Reservoirs
|
$239,486 |
-
|
0 |
| 84.423 |
Passed Through University of Alabama: Social and Emotional Learning Study Groups for Educators of Students with Emotional and Behavioral Disorders (selsg+)
|
$237,772 |
-
|
0 |
| 93.866 |
Passed Through Duke University: Alzheimer's Gut Microbiome Project
|
$237,581 |
-
|
0 |
| 93.855 |
National Institute of Health:covid Mitigating Covid-19 Transmission in U.s. Jails
|
$236,354 |
-
|
0 |
| 84.063 |
U.s. Department of Education: Pell Grant Program
|
$226,377 |
-
|
0 |
| 93.242 |
Passed Through Argus Cognitive Inc: Argus-Mds: Automated, Quantitative and Scalable System for Social Processes in Behavioral Health
|
$204,569 |
-
|
0 |
| 93.855 |
Passed Through Northwestern University: Functionally Defining Hiv-Host Interactions During the Early Hiv-1 Lifecycle
|
$196,140 |
-
|
0 |
| 93.RD |
Passed Through Westat Inc: Nichd International and Domestic Pediatric and Maternal Hiv Studies Coordinating Center
|
$178,760 |
-
|
0 |
| 93.RD |
Passed Through Cdc: Candida Auris, An Emerging Fingal Pathogen of High Concern
|
$178,328 |
-
|
0 |
| 93.866 |
Passed Through Northwestern University: Molecular Mechanisms Underlying Behavioral and Psychological Symptoms in Alzheimers Disease
|
$170,617 |
-
|
0 |
| 93.866 |
Passed Through Wake Forest University Health: US Pointer Imaging Ancillary Study
|
$166,401 |
-
|
0 |
| 84.305 |
Department of Education: Validation of A Spanish-Language Social Reasoningassessment for Spanish-Speaking English Language Learners
|
$164,582 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Alzheimer's Clinical Trial Consortium (actc)
|
$162,758 |
-
|
0 |
| 93.247 |
Passed Through Heartland Health Center: Advanced Nursing Education Nurse Practitioner Residency
|
$160,672 |
-
|
0 |
| 93.855 |
Passed Through Northwestern University: Food Allergy Outcomes Related to White and African American Racial Differences (forward)
|
$159,247 |
-
|
0 |
| 93.866 |
Passed Through Northwestern University: Genetic Modifiers of the Mediterranean-Dash Dieton Mri Amongst A Diverse Population with Cognitive Complaint Intervention for Neurodegenerative Delay (mind) Response
|
$156,961 |
-
|
0 |
| 93.866 |
Passed Through University of Alabama: Identifying Therapeutic Targets That Confer Synaptic Resilience to Alzheimer's Disease
|
$153,023 |
-
|
0 |
| 93.846 |
Passed Through Baylor College of Medicine: Mechanisms of Couplon-Linked Skeletal Muscle Myopathies
|
$149,746 |
-
|
0 |
| 93.866 |
Passed Through Emory University: Understanding the Molecular Mechanisms of Depression Andpsychological Well-Being in Alzheimer's Disease
|
$148,235 |
-
|
0 |
| 93.866 |
Passed Through University of Florida: the Role of Elevated Bin1 Expression in Alzheimer's Disease
|
$138,599 |
-
|
0 |
| 93.853 |
Passed Through Iit: Clinical Test of An Intracortical Visual Prothesis System
|
$134,649 |
-
|
0 |
| 93.866 |
Passed Through University of Florida: Genome-Wide Profiling of Brain 6ma Methylome in Ad
|
$132,519 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Metformin in Alzheimer's Dementia Prevention (map)
|
$127,046 |
-
|
0 |
| 93.242 |
Passed Through Northwestern University: Technology Enabled Services for Coordinated Care of Depression in Healthcare Settings
|
$123,912 |
-
|
0 |
| 93.837 |
Passed Through Hektoen: MacS/wihs Combined Cohort Study: Cook Countyclinical Research Site (cc_crs)
|
$123,080 |
-
|
0 |
| 93.847 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Cd40 Autoantibody and Fsgs Recurrence
|
$120,267 |
-
|
0 |
| 93.866 |
Passed Through Boston University/boston Childrens Hospital: Air Pollution and Noise Exposures in Relation to Dementia:from Brain Imaging Markers to Clinical Disease
|
$118,721 |
-
|
0 |
| 93.865 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla A Cognitive Test Battery for Intellectual Disabilities
|
$116,677 |
-
|
0 |
| 93.866 |
Passed Through Vanderbilt University: Proteomics of Hypertension and Alzheimer's Disease Inafrican American
|
$111,423 |
-
|
0 |
| 93.866 |
Passed Through Beth Israel: Establishing Sleep Apnea As A Non-Cognitive Phenotype of Brainstem Adrd Pathologies in Older Adults
|
$108,066 |
-
|
0 |
| 93.242 |
Passed Through Northwestern University: A Family- Genetic Study of Autism and Fragile X Syndrome
|
$107,026 |
-
|
0 |
| 93.855 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Aids Clinical Trials Group for Research on Therapeutics for Hiv and Related Infections Actg Loc: Spec Lab A5369/a5371
|
$106,796 |
-
|
0 |
| 93.846 |
Passed Through University of Pennyslvania: Modulation of Inflammation in Osteoarthritis Via Cd14-Mediated Pattern Recognition
|
$98,017 |
-
|
0 |
| 93.866 |
Passed Through University of Chicago: Adaptive Testing of Cognitive Function Based on Multidimensional Item Response Theory
|
$96,793 |
-
|
0 |
| 93.866 |
Passed Through Yale University: Molecular Networks Underlying Resilience Toalzheimer's Disease Among Apoe E4 Carriers
|
$94,217 |
-
|
0 |
| 93.855 |
Passed Through Fred Hutchinson Cancer Center: Covid-19 Prevention Network (covpn)- Site Preparedness Funding -Chicago- Rush Protocol Specific Site
|
$94,200 |
-
|
0 |
| 93.866 |
Passed Through Boston University/boston Childrens Hospital: Air Pollution and Alzheimer's Dementia: Neuropathologic and Olfactory Mechanisms in Multi-Ethnic Longitudinal Cohorts
|
$94,099 |
-
|
0 |
| 93.866 |
Passed Through Mt. Sinai: A Multiscale Investigation of the Living Human Brain
|
$93,982 |
-
|
0 |
| 93.226 |
Passed Through City of Hope: PA-20-070 "development of Evidence-Based Decision Supportfor the Management of Covid19"
|
$93,574 |
-
|
0 |
| 93.855 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Aids Clinical Trial Group Laboratory Center (actg Lc)
|
$91,226 |
-
|
0 |
| 93.323 |
Passed Through City of Chicago-Chicago Department of Public Health: Elc Program Contact Tracing
|
$88,799 |
Yes
|
0 |
| 93.866 |
Passed Through Tufts University: Vitamins D and K Neuropathologically-Defined Alzheimer and Other Dementias in Older Persons
|
$87,576 |
-
|
0 |
| 93.866 |
Passed Through Edgewater Safety Systems: Development of Memesto, A Wearable Repetitive Message and Music Therapy Device That Senses and Reduces Agitation in Persons with Ad/adrd.
|
$87,567 |
-
|
0 |
| 93.RD |
Passed Through Cdc: Evaluating Emergence of Resistance and Changesin Clinical Pathogens Following Introduction of Chlorhexidine Bathing
|
$87,377 |
-
|
0 |
| 93.242 |
Passed Through Depaul University: Preventing Suicide in African American Adolescents
|
$86,778 |
-
|
0 |
| 93.866 |
Passed Through University of Kentucky: Role of Impaired Cognitive States & Risk Factors Inconversion to Mixed Dementias
|
$86,616 |
-
|
0 |
| 93.279 |
National Institute of Health:covid Covid-Great Lakes Node of the Drug Abuse Clinical Trials Network
|
$86,163 |
-
|
0 |
| 93.855 |
Passed Through Emory University: the Mechanism of Arenavirus Entry Into Cells
|
$85,887 |
-
|
0 |
| 93.RD |
Passed Through Cdc: Evaluating Sars-Cov-2 Vaccine Effectiveness Among Healthcare Personnel During Early Phase, Post-Introduction Vaccination
|
$85,112 |
-
|
0 |
| 93.342 |
U.s. Department of Health and Human Services: Primary Care Loan/hpsl-Outstanding Loan Bal. at Measurement Date
|
$85,089 |
-
|
0 |
| 84.268 |
U.s. Department of Education: Parent Loans for Undergraduate Students
|
$83,113 |
-
|
0 |
| 84.007 |
U.s. Department of Education: Supplemental Educational Opportunity Grant
|
$82,497 |
-
|
0 |
| 12.420 |
U.s. Army Medical Research Acquisition Activity: Targeting Diet-Microbiome Interactions in Thepathogenesis of Parkinson's Disease
|
$82,115 |
-
|
0 |
| 93.837 |
Passed Through University of Chicago: Genotype-Quided Therapy for Atrial Fibrillation
|
$80,879 |
-
|
0 |
| 93.264 |
U.s. Department of Health and Human Services: Nurse Faculty Loan Program
|
$80,749 |
-
|
0 |
| 93.855 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Aids Clinical Trials Group- Protocol Pifa5401
|
$80,350 |
-
|
0 |
| 93.847 |
Passed Through University of Pennyslvania: Impact of Daytime Vs. Delayed Eating Schedule on Weight and Metabolic Markers Among Obese Persons: An Examinationof Circadian Mechanisms.
|
$80,204 |
-
|
0 |
| 93.172 |
Passed Through University of Washington: Literacy Development for Preschoolers with Hearing Loss
|
$80,049 |
-
|
0 |
| 93.350 |
Passed Through University of Chicago: Advancing Translational Science in Metropolitian Chicago-Kl2 Component
|
$79,635 |
-
|
0 |
| 93.866 |
Passed Through Brigham and Women's Hospital: Integrative Motor Activity Biomarker for the Riskof Alzheimer's Risk
|
$78,357 |
-
|
0 |
| 12.420 |
U.s. Army Medical Research Acquisition Activity: Rational Targeting of Ttk/mps1 in Her2-Negative Breast Cancer
|
$75,609 |
-
|
0 |
| 93.364 |
U.s. Department of Health and Human Services: Nursing Student Loan
|
$75,148 |
-
|
0 |
| 93.395 |
Passed Through Brigham and Women's Hospital: Alliance for Clinical Trials in Oncology Operations Center
|
$75,055 |
-
|
0 |
| 93.866 |
Passed Through Duke University: Pragmatic Evaluation of Events and Benefits of Lipid-Lowering in Older Adults (preventable)
|
$72,465 |
-
|
0 |
| 93.838 |
Passed Through University of Chicago: Chicago Metropolitan Asthma Consortium Forsevere/exacerbation-Prone Asthma
|
$71,680 |
-
|
0 |
| 93.866 |
Passed Through Hennepin Healthcare Research: Aspirin in Reducing Events in the Elderly Extensionaspree
|
$71,625 |
-
|
0 |
| 93.408 |
U.s. Department of Health and Human Services: Nurse Faculty Loan Program-Outstanding Loan Bal. at Measurement Date-Arra
|
$70,173 |
-
|
0 |
| 43.003 |
Passed Through Nasa: Single-Source, Biomarkers As Predictors of Resiliency and Susceptibility to Stress in Space Flight
|
$69,972 |
-
|
0 |
| 93.838 |
Passed Thru University of North Carolina at Chapel Hill: Data, Modeling, and Coordination Center for Precise Network
|
$69,518 |
-
|
0 |
| 93.853 |
Passed Through Neuronext- Novartis and Massachusetts General Hospital: Effects of Afq056 on Language Learning in Young Childrenwith Fragile X Syndrome (fxs)
|
$68,103 |
-
|
0 |
| 14.921 |
U.s. Department of Housing and Urban Development (hud): Older Adults Home Modification Grant Program
|
$68,056 |
-
|
0 |
| 93.853 |
Passed Through Cleveland Clinic: Dementia with Lewy Bodies Consortium
|
$66,884 |
-
|
0 |
| 93.846 |
Passed Through University of Virginia: Systems Genetics of Bone Regeneration
|
$66,244 |
-
|
0 |
| 93.838 |
Passed Through University of Chicago: Nih Community Engagement Alliance (ceal) Against Covid-19 Disparities
|
$65,461 |
-
|
0 |
| 93.866 |
Passed Through Washington University: Bidirectional Interactions Between Sleep and Alzheimer's Disease: Functional Dissection of the Brain Transcriptome in Humans and Drosophila
|
$64,772 |
-
|
0 |
| 93.350 |
Passed Through University of Chicago: Ctsa Grant
|
$64,723 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Alzheimer's Disease Neuroimaging Initiative 2 (adni2)
|
$64,343 |
-
|
0 |
| 93.940 |
Passed Through City of Chicago-Chicago Department of Public Health: Expanded Hiv Testing for Disproportionately Affected Populations
|
$64,208 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Uc Davis Alzheimer's Disease Center
|
$63,725 |
-
|
0 |
| 93.866 |
Passed Through Mt. Sinai: Integrative Network Modeling of Cognitive Resilience Toalzheimer's Disease
|
$62,422 |
-
|
0 |
| 93.865 |
National Institute of Health:covid Effects of Face Masks on Word Learning in Preschool-Age Children
|
$62,393 |
-
|
0 |
| 93.866 |
Passed Through Banner Health: Neurobiology of Mild Cognitive Impairment in the Elderly
|
$60,369 |
-
|
0 |
| 12.420 |
Passed Through University of Melbourne: the Role of An Aggrecan 32mer Fragment in Post-Traumatic Osteoarthritis
|
$58,724 |
-
|
0 |
| 93.RD |
Passed Through Pacific Northwest Nat'l Lab (pnnl): Promotr: A Proteomics Center for Motrpac Statement of Work
|
$56,640 |
-
|
0 |
| 93.865 |
Passed Through Ohio State University: Parent Training for Parents of Toddlers Born Very Premature: A Factorial Design to Test Web Delivery and Telephone Coaching
|
$55,865 |
-
|
0 |
| 93.855 |
Passed Through University of Illinois: Discovery of Novel Smhdacs Inhibitors for the Treatment of Schistosomiasis
|
$54,099 |
-
|
0 |
| 93.395 |
Passed Through Washington University: Exploiting Integrin Signaling to Overcome Resistanceto Immunotherapy
|
$50,528 |
-
|
0 |
| 93.866 |
Passed Through Dignitiy Health: Neurobiology of Mild Cognitive Impariment in the Elderly
|
$49,242 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease
|
$48,245 |
-
|
0 |
| 93.866 |
Passed Through Baylor College of Medicine: Functional Validation of the Cd1ap Susceptibility Network Inalzheimer's Disease
|
$47,830 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Alzheimer's Disease Cooperative Study - A4 Study
|
$47,532 |
-
|
0 |
| 93.350 |
Passed Through University of Chicago: Itm 2.0: Advancing Translational Science in Metropolitanchicago
|
$47,449 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Ethnic-Specific Effects of Mitochondrial Dna Variants and Environmental Factors on Cognitive Functioning and Dementia
|
$45,782 |
-
|
0 |
| 84.305 |
Department of Education: Web-Based Assesment of Social-Emotional Learning in Grades Four to Six
|
$44,422 |
-
|
0 |
| 93.394 |
Passed Through University of Hawaii: Profiling Genome-Wide Circulating Ncrnas for the Early Detection of Lung Cancer
|
$44,102 |
-
|
0 |
| 93.866 |
Passed Through University of Wisconsin: the Neighborhoods Study: Contextual Disadvantage and Alzheimer's Disease and Related Dementias (adrd)
|
$44,098 |
-
|
0 |
| 93.866 |
Passed Through Vanderbilt University: Genetic Drivers of Resilience to Alzheimer's Disease
|
$43,527 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Interrogation of A Human Microglia Phenotype Associated with Alzheimer's Disease
|
$43,283 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Nia Late Onset of Alzheimer's Disease (load)family Based Study
|
$42,978 |
-
|
0 |
| 93.855 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Impact of Reproductive Aging on Hiv Persistence and Inflammation
|
$42,536 |
-
|
0 |
| 96.007 |
Passed Through University of Wisconsin: Center for Financial Security Retirement and Disability Research Consortium
|
$42,353 |
-
|
0 |
| 93.866 |
Passed Through Wright State University: Differential Clearance of Pyroglutamate Abeta Througharachnoid Meningeal Lymphatics in Ad
|
$41,939 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Global Alzheimer's Platform Trial-Ready Cohort Forpreclinical/prodromal Ad
|
$41,039 |
-
|
0 |
| 93.847 |
Passed Through Mt. Sinai: Elucidating Genetic and Environmental Second Hits in Racial and Ethnic Minorities with Apol1 High-Risk Genotypes
|
$40,695 |
-
|
0 |
| 93.866 |
Passed Through Vanderbilt University: Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
|
$40,659 |
-
|
0 |
| 93.866 |
Passed Through Duke University: Metabolomic Signatures for Disease Sub-Classification and Target Prioritization in Amp-Ad
|
$40,102 |
-
|
0 |
| 93.233 |
Passed Through University of Utah: Circadian and Sleep Pathways to Cardiometabolic Disease Risk: Role of Neurobehavioral Processes
|
$39,983 |
-
|
0 |
| 93.847 |
Passed Through University of Alabama: Role of Vitamin D in the Prevention and Progression Ofurinary Incontinence
|
$39,880 |
-
|
0 |
| 93.866 |
Passed Through Brigham and Women's Hospital: Fractal Motor Activity Regulation and the Risk for Alzheimers Disease in Middle to Old Age Adults
|
$39,248 |
-
|
0 |
| 93.837 |
Passed Through University of Pittsburgh: Siv Pathogenesis in African Green Monkeys and Pigtailed MacAques
|
$39,209 |
-
|
0 |
| 93.279 |
Passed Through Vanderbilt University: Stress and Opioid Misuse Risk: the Role of Endogenous Opioid and Endocannabinoid Mechanisms
|
$38,135 |
-
|
0 |
| 93.866 |
Passed Through Iit: Comprehensive Probabilistic Atlas of the Brain of Older Adults Without Dementia
|
$38,130 |
-
|
0 |
| 93.226 |
Passed Through University of Chicago: Targeted Healthcare Engineering for Systems Interventions in Stroke (thesis)
|
$37,355 |
-
|
0 |
| 93.840 |
Passed Through Northwestern University: Community Intervention to Reduce Cardiovascular Disease in Chicago (circl-Chicago)
|
$36,978 |
-
|
0 |
| 93.184 |
Passed Through Great Lakes Hemophilia: Regional Program
|
$36,606 |
-
|
0 |
| 93.847 |
Passed Through University of Wisconsin: Apollo - Upper Midwest
|
$36,533 |
-
|
0 |
| 93.866 |
Passed Through Oregon Health and Science Institute: Personality and Health: A Longitudinal Study
|
$36,264 |
-
|
0 |
| 93.RD |
Passed Through Medical Research Analytics and Informatics Alliance (mraia): Covid-19-Baa Secondary and Antimicrobial-Resistant Infections Risk, and Antimicrobial Use Among Covid-19 Infected Patients: A Multicenter Evaluation (sars-Risk)
|
$36,205 |
-
|
0 |
| 93.853 |
Passed Through Boston Childrens Hospital: Development of Synaptopathies Associated with Tsc, Pten, Shank3 Mutations
|
$34,804 |
-
|
0 |
| 93.853 |
Passed Through Van Andel Research Institute: Combining Synucleinopathy and Mitochondrial Deficits in A Novel Mouse Model of Parkinsons Disease
|
$34,129 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Microglia Antigen Presentation in the Cns of Alzheimer's Disease
|
$33,903 |
-
|
0 |
| 93.124 |
U.s. Department of Health and Human Services: Nurse Anesthetist Traineeships
|
$33,130 |
-
|
0 |
| 93.853 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla the Clinical Significance of Incidental White Matter Lesionson Mri Amongst A Diverse Population with Cognitive Complaint (indeed)
|
$32,073 |
-
|
0 |
| 93.853 |
Passed Through Northwestern University: Glutamate Receptor Signaling Pathways in the Circuit Integration of Adult-Born Neurons.
|
$31,698 |
-
|
0 |
| 93.866 |
Passed Thru Harvard School of Public Health: Optimism and Exceptional Longevity (supplement)
|
$30,262 |
-
|
0 |
| 93.RD |
Passed Through Massachusetts General Hospital: Phase Ii/iii Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (impt) Or Photon (imrt) with Simultaneously Integrated Boost to the High Risk Margin for Retroperitoneal Sarcomas
|
$29,956 |
-
|
0 |
| 93.080 |
Passed Through Great Lakes Hemophilia: Public Health Surveillance for Bleeding Disorders
|
$29,891 |
-
|
0 |
| 93.866 |
Passed Thru University of North Carolina at Chapel Hill: Oxidative Stress and the Development of Osteoarthritis
|
$29,383 |
-
|
0 |
| 93.866 |
Passed Through University of Washington: Aids and Aging Research Platform (aarp)
|
$29,371 |
-
|
0 |
| 93.113 |
Passed Through New York University: Developmental Origins of Kidney Function in Early Life and Environmental Risks.
|
$28,606 |
-
|
0 |
| 93.855 |
Passed Through Wistar Institute: Beat-Hiv: Delaney Collaboratory to Cure Hiv-1 Infection by Combination Immunotherapy
|
$27,814 |
-
|
0 |
| 93.RD |
Passed Through National Fragile Foundation: Forward Registry and Database
|
$27,538 |
-
|
0 |
| 93.866 |
Passed Thru University of Indiana: National Cell Repository for Alzheimer's Disease (ncrad)
|
$27,292 |
-
|
0 |
| 93.395 |
Passed Through Fox Chase Chem Diversity Center: Riluzole Prodrugs for Melanoma and Als
|
$26,961 |
-
|
0 |
| 93.853 |
Passed Through Northwestern University: Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: Sparx3
|
$26,449 |
-
|
0 |
| 93.847 |
Passed Through Massachusetts General Hospital: Dynamin, Actin and Microtubules: Cystiskeletal Crosstalk in Podocytes
|
$26,363 |
-
|
0 |
| 93.RD |
Passed Through Westat Inc: Nichd International and Domestic Pediatric Andmaternal Hiv Studies Coordinating Center
|
$26,063 |
-
|
0 |
| 93.350 |
Passed Through University of Colorado: A National Center for Digital Health Informatics Innovation
|
$25,956 |
-
|
0 |
| 93.345 |
Passed Through Boston Childrens Hospital: Cumulus: A Universal Research Sidecar for A Smart Learning Healthcare System
|
$25,775 |
-
|
0 |
| 93.866 |
Passed Through Duke University: Pragmatic Evaluation of Events and Benefits of Lipid-Lowering in Older Adults (preventable) -Administration & Trial Management
|
$25,717 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Unraveling the Intersection of Synaptic Biology, Lifestyle, and Cognitive Resilience
|
$25,526 |
-
|
0 |
| 93.866 |
Passed Thru Harvard School of Public Health: Targeting Rest in Alzheimer's Disease
|
$24,667 |
-
|
0 |
| 93.110 |
Passed Through University of Illinois: State Maternal Health Innovation Prrogram
|
$24,344 |
-
|
0 |
| 93.866 |
Passed Through University of Washington: Adni Psychometrics
|
$23,722 |
-
|
0 |
| 93.233 |
Passed Through Loyola University: Mets-Sleep: Sleep Timing, Gut Microbiota Andcardiometabolic Risk Across the Epidemiologic Transition
|
$23,540 |
-
|
0 |
| 93.853 |
Passed Through Massachusetts General Hospital: Recurrent Hemorrhagic Stroke in Minority Populations
|
$23,516 |
-
|
0 |
| 93.846 |
Passed Through Iit: Gradient Hydrogels to Promote Msc Differentiatiation for Osteochondral Defect Repair
|
$23,366 |
-
|
0 |
| 93.886 |
Passed Through Massachusetts General Hospital: Prospective Study of the Gut Microbiome in Aging
|
$22,812 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Alzheimer's Disease Neuroimaging Initiative (adn13)
|
$22,789 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Convergence of Myeloid Susceptibility Protein Function in Alzheimer's Disease
|
$22,314 |
-
|
0 |
| 93.837 |
Passed Through Northwestern University: Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: the Impact of Hiv/siv, Art and Targeted Immunotherapy
|
$22,236 |
-
|
0 |
| 93.364 |
U.s. Department of Health and Human Services: Nursing Student Loan-Undergraduate-Outstanding Loan Bal. at Measurement Date
|
$22,222 |
-
|
0 |
| 93.866 |
Passed Through Vanderbilt University: Sex-Specific Genetic Drivers of Alzheimer's Disease Endophenotypes
|
$21,356 |
-
|
0 |
| 93.853 |
Passed Through University of Texas: Clinical Pathological Study of Cognitive Impairment in Essential Tremor
|
$21,095 |
-
|
0 |
| 93.866 |
Passed Through Emory University: Preparation for End-of-Life Decision Making in Mild Alzheimer's Disease
|
$20,815 |
-
|
0 |
| 93.279 |
Passed Through University of Wisconsin: Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
|
$20,670 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Early Vascular Contributions to Dementia Risk Inafrican-Americans
|
$20,631 |
-
|
0 |
| 93.837 |
Passed Through Albert Einstein College of Medicine: Immunophenotyping for Precision Medicine for Cadiovasculardisease in People Living Wit Hiv
|
$20,583 |
-
|
0 |
| 93.RD |
Passed Through Age Options: Mental Health Services
|
$20,198 |
-
|
0 |
| 93.866 |
Passed Through Wistar Institute: Sialicnacid Modulation of Hiv-Associatedchronic Inflammaging
|
$20,020 |
-
|
0 |
| 93.866 |
Passed Through Purdue University: Childhood Misfortune and Adult Health Among Black, White,and Hispanic Americans
|
$19,162 |
-
|
0 |
| 93.866 |
Passed Through Emory University: Elucidating the Role of Plasma Cholesterol Inalzheimer's Disease Using Mendelian
|
$18,917 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Lifecourse Exposure to Community Violence and Risk Risk of Cognitive Decline, Alzheimer's Disease, and Related Dementias Among African-Americans
|
$18,877 |
-
|
0 |
| 93.837 |
Passed Through University of Michigan/michigan State: Role of Supar in the Intersection Between Cardiovascular and Kidney Disease
|
$18,837 |
-
|
0 |
| 93.866 |
Passed Through Emory University: Roybal Translational Research Center to Promotecontext-Specific Caregiving Master
|
$18,431 |
-
|
0 |
| 93.853 |
Passed Through University of Pennyslvania: Connect - Tbi
|
$18,325 |
-
|
0 |
| 93.855 |
Passed Through Northwestern University: Chicago Clinical Trial Unit
|
$18,266 |
-
|
0 |
| 93.859 |
Passed Through Emory University: Novel Bayesian Statistical Tools for Integrating Multi-Omics Data to Help Elucidate the Genomic Etiology of Complexphenotypes
|
$18,210 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Limited Stage Small Cell Lung Cancer (ls-Sclc): A Phase Ii/iii Randomized Study of Chemoradiation Vs Chemoradiation Plus Atezolizumab
|
$17,851 |
-
|
0 |
| 93.RD |
Passed Through University of Mississippi: Jackson Heart Study Coordinating Center
|
$17,763 |
-
|
0 |
| 93.307 |
Passed Through University of Illinois: Center for Health Equity Research (cher)
|
$17,449 |
-
|
0 |
| 93.837 |
Passed Through Hektoen: MacS/wihs Combined Cohort Study; Cook County Clinical Research Site ( Cc_crs)
|
$17,098 |
-
|
0 |
| 93.173 |
Passed Through Medical College of Wisconsin: Environmental Sound Recognition Before and After Cochlear Implantation in Adults
|
$16,550 |
-
|
0 |
| 12.420 |
Passed Through University of Maryland: Cooling to Help Injured Lungs (chill Phase Iib Randomized Control Trial of Therapeutic Hypothermia in Patients with Ards
|
$16,463 |
-
|
0 |
| 93.847 |
Passed Through Wistar Institute: Role of Intestinal Barrier Integrity in Modulating the Host Glycome During Covid-19
|
$16,460 |
-
|
0 |
| 93.866 |
Passed Through Purdue University: Disparities in the Life Course Origins of Cognitive Decline
|
$16,428 |
-
|
0 |
| 93.307 |
Passed Through University of Chicago: Chicago Chronic Condition Equity Network (c3en)
|
$16,109 |
-
|
0 |
| 93.859 |
Passed Through University of Utah: Center for the Structural Biology of Cellular Host Elementsin Egress, Trafficking, and Assembly of Hiv (cheetah Center)
|
$16,088 |
-
|
0 |
| 93.866 |
Passed Through University of Illinois: A Dynamic Environmental Exposure Approach to Study Behaviorsin Mid-Life.
|
$15,967 |
-
|
0 |
| 93.226 |
Passed Through Northwestern University: PA-20-072: Supplement Toa Chicago Center of Excellence in Learning Health Systems Research Training (accelerat)
|
$15,942 |
-
|
0 |
| 93.395 |
Passed Through University of Florida: Dignity Therapy Rct Led by Nurses of Chaplains for Elderly Cancer Outpatients
|
$15,280 |
-
|
0 |
| 93.866 |
Passed Through Columbia University: Blood Pressure and Adrd in African Americansthe Jackson Heart Study
|
$15,147 |
-
|
0 |
| 93.107 |
Passed Through University of Illinois: Ahec Point of Service Maint & Enhancement
|
$14,844 |
-
|
0 |
| 93.847 |
Passed Thru George Washington University: Progress in Diabetes Genetics in Youth (prodigy) Data Analysis Under the Today2 Phase 2 (t2p2) Study
|
$14,680 |
-
|
0 |
| 93.837 |
Passed Through Hektoen: MacS/wihs Combined Cohart Study; Cook County Clinical Research Site ( Cc_crs)
|
$14,572 |
-
|
0 |
| 93.865 |
Passed Through University of Wisconsin: Fmr1 Premutation Phenotypes in Population-Based and Clinically-Ascertained Samples
|
$14,366 |
-
|
0 |
| 12.420 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Effects of Traumatic Brain Injury and Post Traumatic Stress Disorder on Alzheimer's Disease in Veterans Using Adni
|
$14,348 |
-
|
0 |
| 93.837 |
Passed Through Children's Hospital: Impact of Well-Timed Vs. Mis-Timed Sleep Extension on Adolescents' Dietary Intake
|
$14,199 |
-
|
0 |
| 93.866 |
Passed Through University of Illinois: the Role of Mid-Life Psychosocial Stressors,social Resources and Physiological Dysregulation
|
$13,720 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla the A3study: Ante-Amyloid Prevention of Alzheimer's Disease
|
$13,355 |
-
|
0 |
| 93.103 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Angelman Syndrome Natural History Study
|
$12,083 |
-
|
0 |
| 93.847 |
Passed Through Northwestern University: the Effects of Capsinoids on Brown Adipose Tissue Recruitment and Activation in Obesity
|
$11,900 |
-
|
0 |
| 93.855 |
Passed Through Northwestern University: Successful Clinical Response in Pneumonia Therapy (script) Systems Biology Center
|
$11,891 |
-
|
0 |
| 93.RD |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Evaluating Changes in Skin Cultures and Skin Microbiome Due to Chlorhexidine Vs. Soap Bathing in Patients Requiring Acute Or Long Term Care in Healthcare Facilities
|
$11,701 |
-
|
0 |
| 93.110 |
Passed Through University of Illinois: Leadership Education in Neurodevelopmental and Related Disabilities Training Program
|
$11,689 |
-
|
0 |
| 93.855 |
Passed Through Johns Hopkins: Loc - Impaact Leadership Group
|
$11,602 |
-
|
0 |
| 47.074 |
Passed Through National Science Foundation: Collaborative Research:rapid:molecular Underpinnings That Define Volatile Compound Signature of the Lung
|
$11,412 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla the A3 Study; Ante-Amyloid Prevention of Alzheimer's Disease
|
$11,246 |
-
|
0 |
| 93.837 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Akap-Dependent Regulation of Cardiac SR Ca Handling
|
$11,128 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease
|
$10,618 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Uc Davis Alzheimer's Disease Core Center
|
$9,435 |
-
|
0 |
| 93.866 |
Passed Through Wake Forest University Health: Pointer-Zzz: Sleep Ancillary to U.s. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk Ofalzheimer's Disease
|
$8,964 |
-
|
0 |
| 93.RD |
Passed Through Social and Scientific Systems: A Multicenter Platform Trial of Putative Therapeutics for the Treatment of Covid-19 in Hospitalized Adults (bet)
|
$8,636 |
-
|
0 |
| 93.242 |
Passed Through Intl Rett Syndrome: Rett Syndrome, Mecp2 Duplications, and Rett-Related Disorder Natural History
|
$8,465 |
-
|
0 |
| 93.RD |
Passed Through Wake Forest University Health: Alzheimer's Gut Microbiome Project
|
$8,087 |
-
|
0 |
| 93.837 |
Passed Through Albert Einstein College of Medicine: Integrated Analysis of Cvd Risk in Hiv: Gutmicrobiota, Immune Function and Metabolites
|
$7,548 |
-
|
0 |
| 93.866 |
Passed Through University of Minnesota: Soluble Asyn Is A Modulator of Ad Pathophysiology
|
$7,514 |
-
|
0 |
| 93.838 |
Passed Through Pro Change Behavior Systems: Fhir-Ed Up for Tobacco Cessation
|
$7,217 |
-
|
0 |
| 93.866 |
Passed Through University of Pittsburgh: the Study of Women's Health Across the Nation (swan): the Impact of Midlife and the Menopause Transition on Health on Health and Functioning in Early Old Age
|
$7,054 |
-
|
0 |
| 93.837 |
Passed Through Massachusetts General Hospital: Randomized Trial to Prevent Vascular Events in Hiv - Reprieve
|
$5,519 |
-
|
0 |
| 93.310 |
Passed Through University of Pittsburgh: Building Up
|
$5,054 |
-
|
0 |
| 93.110 |
Passed Through University of Illinois: Leadership Education in Neurodevelopmental and Related Disorders Training Program
|
$5,022 |
-
|
0 |
| 93.855 |
Passed Through Johns Hopkins: Hope in Action: A Clinical Trial of Hiv-to-Hiv Liver Liver Transplantation
|
$5,000 |
-
|
0 |
| 93.866 |
Passed Through Wake Forest University Health: the Pointer Neurovascular Ancillary Study
|
$4,741 |
-
|
0 |
| 93.853 |
Passed Through Augusta University: Mechanisms of Estrogen Signaling and Neuroprotection
|
$4,641 |
-
|
0 |
| 93.866 |
Passed Through University of Michigan/michigan State: Swan Genomic Analyses and Swan Legacy
|
$4,531 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients with Chronic Lymphocytic Leukemia
|
$4,038 |
-
|
0 |
| 93.839 |
Passed Through Rutgers University: Myocardial Ischemia and Transfusion Mint
|
$4,012 |
-
|
0 |
| 93.136 |
Passed Through University of Chicago: Chicago Center for Youth Violence Prevention
|
$3,781 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Randomized Phase II Trial in Early Relapsing Orrefractory Follicular Lymphoma
|
$3,578 |
-
|
0 |
| 93.866 |
Passed Through Rutgers University: Asain Resource Centers for Minority Aging Research Rcmar
|
$3,243 |
-
|
0 |
| 93.866 |
Passed Through University of California: Usc, Uc Davis, California Instiitute of Technology, Children Hosp La, Ucla Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/prodromal Alzheimer's Disease
|
$2,468 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Phase Iii, Randomized Study of Nivolumab (opdivo) Or Brentuximab Vedotin (adcetris) Plus Avd in Patients(age >/= 12 Years) with Newly Diagnosed Advancedstage Classical Hodgkin Lymphoma
|
$2,360 |
-
|
0 |
| 93.173 |
Passed Through Northwestern University: A Family Genetic Study of Language in Autism
|
$2,219 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Phase Ib Trial of Neoadjuvant Amg232 Concurrent with Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (sts)
|
$1,814 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Phase II Randomized Study of Adjuvant Versus Neoadjuvant Pembrolizumab for Clinically Detectable Stage III-IV High Risk Melanoma
|
$1,684 |
-
|
0 |
| 93.866 |
Passed Through University of Montreal: Exploring the Role of Il-32 As A Potential Biomarkeran Therapeutic Target in Premature Cardio-Vasculardiseases During Hiv-Infection
|
$1,568 |
-
|
0 |
| 93.866 |
Passed Through Duke University: Pragmatic Evaluation of Events and Benefits of Lipid-Lowering in Older Adults (preventable) - Clinical Sites Core
|
$1,557 |
-
|
0 |
| 93.393 |
Passed Through University of Illinois: Diet Modulation of Bacterial Sulfur & Bile Acidmetabolism and Colon Cancer Risk
|
$1,492 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Phase II Study of Cabozantinib Combination with Nivolumab and Ipilimumab in Rare Genitourinarytumors
|
$1,304 |
-
|
0 |
| 12.420 |
U.s. Army Medical Research Acquisition Activity: Objective Phenotyping in Cervical Dystonia
|
$1,215 |
-
|
0 |
| 93.855 |
Passed Through Duke University: A Phase 2b, Multicenter, Randomized, Open-Label, Assessor Blinded Superiority Study to Compare the Efficacy and for the Completion of Treatment of Patients with Complicated S. Aureus Bacteremia
|
$1,207 |
-
|
0 |
| 93.945 |
Passed Through Northwestern University: Effect of Aca Medicaid Expansion on Diabetes: Diagnosis Treatment, Patient Compliance, & Health Outcomes
|
$1,196 |
-
|
0 |
| 93.867 |
Passed Through Johns Hopkins: Adalimumab Vs. Conventional Immunosuppression for Uveitis(advise) Trial
|
$872 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized Phase II Trial of Radium-223 and Cabozantinib in Patients with Advanced Renal Cell Carcinoma with Bone Metastasis (radical)
|
$821 |
-
|
0 |
| 93.866 |
Passed Through University of Kentucky: Prebiotics Intervention to Reduce Alzheimer's Disease Risk Via Brain-Gut Axis in An Apoe4 Mouse Model
|
$788 |
-
|
0 |
| 93.846 |
Passed Through Northwestern University: Core Center for Clinical Research at Nu
|
$716 |
-
|
0 |
| 93.853 |
Passed Through University of Cincinnati: Multi-Arm Optimization of Stroke Thrombolysis Most Stroke Trial
|
$710 |
-
|
0 |
| 93.084 |
National Institute of Health:covid Covid-Chicago Preventionand Intervention Epicenter II Cpie-II
|
$521 |
-
|
0 |
| 84.305 |
Department of Education: Vesip: Virtual Environment for Social Information Processing Assessment Tool for Upper Elementary and Middle School Children
|
$451 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) the Compassher2 Trials (comprehensive Use of Pathologic Response Assessment to Optimize Therapy in Her2-Positive Breast Cancer): Compassher2 Residual Disease (rd) A Double- Blinded, Phase III Randomized Trial of T-Dm1 and Placebo Com
|
$430 |
-
|
0 |
| 93.855 |
Passed Through Johns Hopkins: Impaact 2019 - Phase I/ii Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/dolutegravir/lamivudine Dispersible and Immediate Release Tablets in Hiv-1-Infected Children Less Than 12 Years of Age
|
$420 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized Phase II Study Comparing Single-Agent Olaparib Single Agent Cediranib and the Combo of Cediranib/olaparib in Women with Recurrent, Persisitent Or Metastic Endometrial Cancer
|
$420 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Mk-3475 As Adjuvant Therapy for Triple Receptor Negative Breast Cancer with >1 Cm Residual Invasive Cancer Or Positive Lymph Nodes After Neoadjuvant Chemotherapy
|
$419 |
-
|
0 |
| 93.853 |
Passed Through University of Cincinnati: Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenicstroke Arcadia
|
$405 |
-
|
0 |
| 93.853 |
Passed Through University of Michigan/michigan State: Genetic Silencing of Striatal Cav1.3 Calcium Channels As A Potent Antidyskinetic Therapy for Pd
|
$399 |
-
|
0 |
| 93.RD |
Passed Through University of Michigan/michigan State: Covid-C3po: Clinical Trial of Covid-19 Convalescent Plasmain Outpatients.
|
$373 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Phase III to Trial to Evaluate the Efficacy of Addition Ofinotuzumab Ozogamin to Frontline Therapyin Young Adultswith Newly Diagnosed Precurso B-Cell All
|
$348 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) S1806: Phase III Randomized Trial of Concurrent Chemoradiotherapy with Or Without Atezolizumab in Localized Muscle Invasive Bladder
|
$311 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Phase III Randomized Adjuvant Study of Pembrolizumab in Muscle Invasive and Locally Advanced Urothelial Carcinoma (ambassador) Versus Observation
|
$273 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Phase I and Expansion Cohort Study of Adjuvant Cisplatin,intensity-Modulated Radiotherapy, and Mk-3475 in High-Riskhead and Neck Squamous Cell Carcinoma
|
$245 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Phase Ii/iii Trial of Adjuvant Radiotherapy and Androgendeprivation Following Radical Prostatectomy with Orwithout Adjuvant Docetaxel
|
$242 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Alchemist: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial
|
$230 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized Phase III Study of A Targeted Therapy Comboversus Ibrutinib and Obinutuzumab in Untreated Youngerpatients with Chrinuc Lymphocytic Leukemia (cll)\
|
$203 |
-
|
0 |
| 93.RD |
Passed Through California Pacific Medical Center: Trial of Parkinson's and Zoledronic Acid (topaz)
|
$176 |
-
|
0 |
| 93.846 |
Passed Through Northwestern University: Lupus Intervention Fatigue Trial (lift)
|
$155 |
-
|
0 |
| 93.855 |
Passed Through Johns Hopkins: Hope in Action: A Clinical Trial of Hiv-to-Hiv Deceased Donor Kidney Transplantation
|
$146 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
|
$102 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized Phase II Study of Nivolumab After Combined Modality Therapy in High Risk Anal Cancer
|
$98 |
-
|
0 |
| 93.279 |
Passed Through Lurie Childrens Hospital: Employing Esbi in A Community-Based Hiv Testing Environment for At-Risk Youth
|
$72 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
|
$53 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (predict-Rt*)
|
$50 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Colorectal Cancer Metastatic Dmmrimmuno-Therapy (commit) Study
|
$49 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Phase II Trial of Smo/akt/nf2 Inhibitors in Progressive Meningiomas with Smo.akt/nf2 Mutations
|
$36 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Phase III Randomized Trial of Standard Systemic Therapy Vs Standard Systemic Therapy Plus Definitive Treatment of Theprimary Tumor in Metastatic Prostate Cancer
|
$24 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Preoperative Thp and Postoperative De-Escalation in Patients Who Achieve A Pathologic Complete Response
|
$22 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Phase III Randomized Trial of Hypofrationated Post Mastectomy Radiation with Breast Reconstruction
|
$9 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) Randomized Phase III Trial Evaluating the Role of Weight Los in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
|
$7 |
-
|
0 |
| 93.RD |
Passed Through Nci-Nctn (ecog, Alliance, Nrg, Swog) A Randomized Double Blind Phass III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Vs Placebin Patients with Relapsed Or Refractory Diffuse Large B-Celllymphoma of the Activated B-Cell Subtype
|
$-168 |
-
|
0 |
| 93.866 |
Passed Through Duke University: Clinical Research Steering Committee Agreement(preventable)
|
$-2,475 |
-
|
0 |
| 93.396 |
Passed Through University of Illinois: Investigation of Cxcr7 Signaling in Egfr Tk1 Resistant Nsclc
|
$-8,725 |
-
|
0 |
| 93.393 |
Passed Through University of Illinois: Diet Modulation of Bacterial Sulfur & Bile Acid Metabolism and Colon Cancer Risk
|
$-15,028 |
-
|
0 |